The groundbreaking therapy of the medication represents a significant breakthrough in the care of type 2 diabetes. Unlike existing medications, tirzepatide targets dual pathways – GLP-1 and the GIP hormone – https://tirzepatidepeptide441370.life3dblog.com/40396831/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment